As of 2026-02-17, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -225.32 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -225,417.50%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 225,417.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -225.32 - -225.32 | -225.32 | -225,417.50% |
| P/E | (674.15) - (818.35) | (802.13) | -802229.6% |
| DDM - Stable | (275.77) - (804.85) | (540.31) | -540413.5% |
| DDM - Multi | (222.66) - (535.29) | (317.93) | -318025.6% |
| Market Cap (mil) | 0.07 |
| Beta | -2.62 |
| Outstanding shares (mil) | 0.67 |
| Enterprise Value (mil) | -4.92 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.24% |
| Cost of Debt | 5.00% |
| WACC | 7.95% |